KBI BioPharma Opens Lab Space And Launches Biopharmaceutics Practice

KBI BioPharma, Inc., a contract biopharmaceutical process development, production and technology company, today announced the launch of its biopharmaceutics practice with the opening of state-of-the-art biopharmaceutical development services laboratories at its 370,000 sq. ft. campus in Durham, N.C. The practice and laboratories will provide analytical method development and validation; preformulation; liquid and lyophilized formulation development; biophysical characterization and accelerated and cGMP (Current Good Manufacturing Practices) stability testing services on a contract basis for recombinant proteins and small molecule drugs.